IB
Ideaya Biosciences Inc
🇺🇸XNAS.IDYAUnited StatesHealthcare
$37.69USDup +0.03 (+0.08%)ClosedDelayed9:47 PM
Price$37.69+0.03 (+0.08%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45166A1025
- CUSIP
- 45166A102
Company
- Employees
- 145
- Headquarters
- South San Francisco, United States
- Website
- https://www.ideayabio.com
- CEO
- Mr. Yujiro S. Hata
Market
- Shares outstanding
- 96.5M
- Market cap
- $3.64B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $3.63B
- EPS LTM
- -$1.90
- P/E LTM
- -19.60
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $234.13M+3,244.67%up year on year
- Net income
- -$175.02M+47.25%up year on year
- Gross margin
- -13.32%+99.33%up year on year
- Free cash flow
- -$190.01M+36.08%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.